# A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

> **NCT00377637** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 370 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate mofetil (MMF)
- **DRUG:** Cyclophosphamide
- **DRUG:** Azathioprine
- **DRUG:** Placebo to Azathioprine
- **DRUG:** Placebo to Mycophenolate mofetil
- **DRUG:** Corticosteroid

## Key facts

- **NCT ID:** NCT00377637
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-03
- **Final completion:** 2010-03
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2011-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377637, "A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00377637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*